Cargando…
Considerations for Assessment and Deployment of Rapid Antigen Tests for Diagnosis of Coronavirus Disease 2019
Diagnostic testing is a critical tool to mitigate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, but molecular testing capacity remains limited. Rapid diagnostic tests (RDTs) that detect SARS-CoV-2 protein antigens (Ag) offer the potential to substantially expand testing...
Autores principales: | Pollock, Nira R, Lee, Francesca, Ginocchio, Christine C, Yao, Joseph D, Humphries, Romney M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989197/ https://www.ncbi.nlm.nih.gov/pubmed/34258309 http://dx.doi.org/10.1093/ofid/ofab110 |
Ejemplares similares
-
To Test, Perchance to Diagnose: Practical Strategies for Severe Acute Respiratory Syndrome Coronavirus 2 Testing
por: Humphries, Romney M, et al.
Publicado: (2021) -
Safety and Considerations of the COVID-19 Vaccine Massive Deployment
por: Li, Junwei, et al.
Publicado: (2021) -
Available drugs and supplements for rapid deployment for treatment of
COVID-19
por: Cicka, Danielle, et al.
Publicado: (2021) -
Deploying digital health tools within large, complex health systems: key considerations for adoption and implementation
por: Marwaha, Jayson S., et al.
Publicado: (2022) -
Rapid Antigen Diagnostics as Frontline Testing in the COVID‐19 Pandemic
por: Xu, Jiang, et al.
Publicado: (2022)